[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  RAH [@RAH00084](/creator/twitter/RAH00084) on x 2467 followers Created: 2025-07-25 07:03:19 UTC $484m Erasca is using Tempus to better define their clinical approach. So is Astra Zeneca, GSK and others. Erasca has a pipeline of X drugs. It has traded over $1Bn market cap this year. None of its drugs are in clinic. #AVCT is valued at $200m, on X years of clinical data.  XXXXX engagements  **Related Topics** [vice president](/topic/vice-president) [artificial](/topic/artificial) [transformative](/topic/transformative) [vice](/topic/vice) [$200m](/topic/$200m) [market cap](/topic/market-cap) [$1bn](/topic/$1bn) [drugs](/topic/drugs) [Post Link](https://x.com/RAH00084/status/1948640187933667613)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RAH @RAH00084 on x 2467 followers
Created: 2025-07-25 07:03:19 UTC
$484m Erasca is using Tempus to better define their clinical approach. So is Astra Zeneca, GSK and others.
Erasca has a pipeline of X drugs. It has traded over $1Bn market cap this year.
None of its drugs are in clinic.
#AVCT is valued at $200m, on X years of clinical data.
XXXXX engagements
Related Topics vice president artificial transformative vice $200m market cap $1bn drugs
/post/tweet::1948640187933667613